NFE2L2 and Parkinson disease: In this context, a couple of preclinical studies have evaluated melatonin’s potential as an inducer of Nrf2 to counteract the molecular pathology (mitochondrial dysfunction, oxidative stress, and protein aggregation) associated with PD (Figure 2).